Clinical Trial Results:
Eine multizentrische, randomisierte, kontrollierte Studie zur Untersuchung von Adalimumab bei der Behandlung verschiedener Formen von refraktärer Uveitis im Vergleich zur Standardtherapie
Randomized controlled study to evaluate the efficacy of Adalimumab in patients with different forms of refractory Uveitis
Summary
|
|
EudraCT number |
2006-001732-53 |
Trial protocol |
DE |
Global completion date |
08 Jan 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
19 Dec 2019
|
First version publication date |
19 Dec 2019
|
Other versions |
|
Summary report(s) |
ADUR-Study summary report |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.